Biomet Retains Heidrick & Struggles and The McLoughlin Company to Assist in CEO Search
05 August 2006 - 2:00AM
Business Wire
Biomet Inc. (NASDAQ:BMET) today announced that it has retained the
services of Heidrick & Struggles, one of the world's premier
executive search and leadership consulting firms, and The
McLoughlin Company, an advisor on institutional management, to
conduct a global search for candidates to serve as Biomet's
President and Chief Executive Officer. Dane A. Miller, PhD,
resigned from the position of President and CEO on March 27, 2006,
at which time Daniel P. Hann assumed the role of Interim President
and CEO. The Board of Directors will carefully consider both
internal and external candidates in its search for a new President
and CEO. It is pleased to partner with respected, top-level firms
like Heidrick & Struggles and The McLoughlin Company. Their use
of best management practices, their global reach and depth of
experience in the medical devices industry will help ensure a
smooth transition to the next era of leadership. Leading the search
team from Heidrick & Struggles are William A. Matthews,
Partner, Atlanta, and David L. Vied, Partner, Los Angeles. Paul
McLoughlin represents The McLoughlin Company. About Heidrick &
Struggles International, Inc. Heidrick & Struggles
International, Inc. (NASDAQ:HSII) is the world's premier provider
of senior-level executive search and leadership consulting
services, including talent management, board building, executive
on-boarding and M&A effectiveness. For more than 50 years, the
company has focused on quality service and built strong leadership
teams through their relationships with clients and individuals
worldwide. Today, their leadership experts operate from principal
business centers in North America, Latin America, Europe and Asia
Pacific. For more information about Heidrick & Struggles, visit
www.heidrick.com. About The McLoughlin Company The McLoughlin
Company is a sole proprietorship providing a broad range of
advisory services to boards, CEOs and senior executive teams at
corporations, not-for-profit institutions, and financial service
firms with focus on senior management, marketing, and technology.
For more information about The McLoughlin Company visit
www.themcloughlincompany.com. About Biomet, Inc. Biomet, Inc. and
its subsidiaries design, manufacture and market products used
primarily by musculoskeletal medical specialists in both surgical
and non-surgical therapy. The Company's product portfolio
encompasses reconstructive products, including orthopedic joint
replacement devices, bone cements and accessories, and dental
reconstructive implants; fixation products, including electrical
bone growth stimulators, internal and external orthopedic fixation
devices, craniomaxillofacial implants and bone substitute
materials; spinal products, including spinal stimulation devices,
spinal hardware and orthobiologics; and other products, such as
arthroscopy products and softgoods and bracing products.
Headquartered in Warsaw, Indiana, Biomet and its subsidiaries
currently distribute products in more than 100 countries.
Biomet (NASDAQ:BMET)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biomet (NASDAQ:BMET)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Biomet (MM) (NASDAQ): 0 recent articles
More Biomet Inc. News Articles